Literature DB >> 25663465

Questions about XY Wen et al. entitled "Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis".

Fanxiao Liu1, Qingyu Zhang.   

Abstract

XY Wen et al. published an article entitled "Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis" in Tumor Biology last year. The investigators demonstrated that high MMP2 expression was associated with poor prognosis in osteosarcoma. After reading these articles, we have some questions about the data extraction and processing in the meta-analysis.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25663465     DOI： 10.1007/s13277-015-3173-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN： 1010-4283


  4 in total

1.  Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma.

Authors:  Mitsutoshi Uchibori; Yoshihiro Nishida; Tetsuro Nagasaka; Yoshihisa Yamada; Keisuke Nakanishi; Naoki Ishiguro
Journal:  Int J Oncol       Date:  2006-01       Impact factor: 5.650

2.  Letter regarding Wen X.Y. et al. entitled "Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis".

Authors:  Hong-bin Guo; Tao Xiao
Journal:  Tumour Biol       Date:  2014-01-22

3.  Matrix metalloproteinases 2, 7, 9 and tissue inhibitor of matrix metalloproteinase-1 in the sera of patients with bone tumors.

Authors:  N E Kushlinsky; Yu N Solovyov; I V Babkina; E S Gershtein; I V Bulicheva
Journal:  Bull Exp Biol Med       Date:  2010-08       Impact factor: 0.804

4.  Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis.

Authors:  Xiaoyang Wen; Hui Liu; Kailong Yu; Yang Liu
Journal:  Tumour Biol       Date:  2013-09-15
  4 in total
  1 in total

1.  Paris saponin VII suppresses osteosarcoma cell migration and invasion by inhibiting MMP‑2/9 production via the p38 MAPK signaling pathway.

Authors:  Gong Cheng; Fengguang Gao; Xiujiang Sun; Haiyong Bi; Yonglin Zhu
Journal:  Mol Med Rep       Date:  2016-08-22       Impact factor: 2.952
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.